Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × seribantumab × Clear all

NCT02387216 2021-10-12

SHERLOC

Phase 2 Terminated

153 enrolled 19 charts

Fibromatosis, Gingival, 2, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung